{"AllianceGenome": "26144", "HGNC": "26144", "MIM": "610355", "_id": "79728", "_version": 1, "accession": {"genomic": ["AC008870.8", "CH471145.2", "CP068262.2", "GM006654.1", "KC877588.1", "MF838935.1", "MF838936.1", "MF991902.1", "MH068860.1", "MK028707.1", "MK028708.1", "NC_000016.10", "NC_060940.1", "NG_007406.1"], "protein": ["AAH44254.1", "ATU89332.1", "ATY46580.1", "AYE20600.1", "AYE20601.1", "AYE20602.1", "AYE20603.1", "AYE20604.1", "AYE20605.1", "AYE20606.1", "AYE20607.1", "AYE20608.1", "AYE20609.1", "BAB15140.1", "BAC05090.1", "BAG61201.1", "CAD39086.1", "CAH18431.1", "CAS97368.1", "EAW55811.1", "EAW55812.1", "EAW55813.1", "NP_001394225.1", "NP_001394226.1", "NP_001394227.1", "NP_001394228.1", "NP_001394229.1", "NP_001394230.1", "NP_001394231.1", "NP_001394233.1", "NP_001394234.1", "NP_001394235.1", "NP_001394236.1", "NP_001394237.1", "NP_001394238.1", "NP_001394239.1", "NP_001394240.1", "NP_001394241.1", "NP_001394242.1", "NP_001394243.1", "NP_078951.2", "Q86YC2.1", "QCL11120.1", "QCL11121.1", "QNJ44867.1", "QTZ96722.1", "UAM96191.1", "UGU37861.1", "WNA08431.1", "WOV89516.1", "WXT91757.1", "WXT91758.1"], "rna": ["AK025469.1", "AK097533.1", "AK299152.1", "AL834425.1", "BC044254.2", "BE670820.1", "BX647125.1", "BX647130.1", "CR749637.1", "DA192828.1", "MG595969.1", "MG595970.1", "MG595971.1", "MG595972.1", "MG595973.1", "MG595974.1", "MG595975.1", "MG595976.1", "MG595977.1", "MG595978.1", "MH068866.1", "MH068867.1", "MH068868.1", "MH068869.1", "MH068870.1", "MH068871.1", "MK028701.1", "MN698974.1", "MN780899.1", "MT313308.1", "MT731959.1", "MW117156.1", "NM_001407296.1", "NM_001407297.1", "NM_001407298.1", "NM_001407299.1", "NM_001407300.1", "NM_001407301.1", "NM_001407302.1", "NM_001407304.1", "NM_001407305.1", "NM_001407306.1", "NM_001407307.1", "NM_001407308.1", "NM_001407309.1", "NM_001407310.1", "NM_001407311.1", "NM_001407312.1", "NM_001407313.1", "NM_001407314.1", "NM_024675.4", "OR267206.1", "OR689406.1", "PP465861.1", "PP465862.1"], "translation": [{"protein": "NP_001394235.1", "rna": "NM_001407306.1"}, {"protein": "UGU37861.1", "rna": "MW117156.1"}, {"protein": "AYE20601.1", "rna": "MG595970.1"}, {"protein": "NP_001394241.1", "rna": "NM_001407312.1"}, {"protein": "NP_001394226.1", "rna": "NM_001407297.1"}, {"protein": "NP_001394236.1", "rna": "NM_001407307.1"}, {"protein": "QTZ96722.1", "rna": "MT313308.1"}, {"protein": "NP_001394238.1", "rna": "NM_001407309.1"}, {"protein": "NP_001394243.1", "rna": "NM_001407314.1"}, {"protein": "AYE20608.1", "rna": "MG595977.1"}, {"protein": "NP_001394227.1", "rna": "NM_001407298.1"}, {"protein": "AAH44254.1", "rna": "BC044254.2"}, {"protein": "NP_001394240.1", "rna": "NM_001407311.1"}, {"protein": "AYE20607.1", "rna": "MG595976.1"}, {"protein": "NP_001394234.1", "rna": "NM_001407305.1"}, {"protein": "CAD39086.1", "rna": "AL834425.1"}, {"protein": "NP_001394239.1", "rna": "NM_001407310.1"}, {"protein": "NP_001394228.1", "rna": "NM_001407299.1"}, {"protein": "BAB15140.1", "rna": "AK025469.1"}, {"protein": "AYE20603.1", "rna": "MG595972.1"}, {"protein": "NP_001394233.1", "rna": "NM_001407304.1"}, {"protein": "BAC05090.1", "rna": "AK097533.1"}, {"protein": "WNA08431.1", "rna": "OR267206.1"}, {"protein": "NP_001394242.1", "rna": "NM_001407313.1"}, {"protein": "AYE20600.1", "rna": "MG595969.1"}, {"protein": "QNJ44867.1", "rna": "MN698974.1"}, {"protein": "NP_001394231.1", "rna": "NM_001407302.1"}, {"protein": "AYE20606.1", "rna": "MG595975.1"}, {"protein": "NP_001394225.1", "rna": "NM_001407296.1"}, {"protein": "NP_001394230.1", "rna": "NM_001407301.1"}, {"protein": "NP_001394237.1", "rna": "NM_001407308.1"}, {"protein": "NP_001394229.1", "rna": "NM_001407300.1"}, {"protein": "UAM96191.1", "rna": "MT731959.1"}, {"protein": "WXT91757.1", "rna": "PP465861.1"}, {"protein": "AYE20602.1", "rna": "MG595971.1"}, {"protein": "CAH18431.1", "rna": "CR749637.1"}, {"protein": "AYE20604.1", "rna": "MG595973.1"}, {"protein": "WOV89516.1", "rna": "OR689406.1"}, {"protein": "AYE20605.1", "rna": "MG595974.1"}, {"protein": "BAG61201.1", "rna": "AK299152.1"}, {"protein": "WXT91758.1", "rna": "PP465862.1"}, {"protein": "AYE20609.1", "rna": "MG595978.1"}, {"protein": "NP_078951.2", "rna": "NM_024675.4"}]}, "alias": ["BROVCA5", "FANCN", "PNCA3"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": [{"classification": "definitive", "classification_date": "2016-12-01T00:00:00", "disease_label": "hereditary breast carcinoma", "gcep": "Breast/Ovarian Cancer Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0016419", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3213", "sop": "SOP4"}, {"classification": "limited", "classification_date": "2018-03-12T00:00:00", "disease_label": "hereditary nonpolyposis colon cancer", "gcep": "Colon Cancer Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0018630", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10073", "sop": "SOP4"}, {"classification": "moderate", "classification_date": "2017-11-08T00:00:00", "disease_label": "familial ovarian cancer", "gcep": "Breast/Ovarian Cancer Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0016248", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9940", "sop": "SOP4"}, {"classification": "definitive", "classification_date": "2019-08-18T16:03:12.829Z", "disease_label": "Fanconi anemia complementation group N", "gcep": "Hereditary Cancer Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0012565", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ebabbf1-1a43-4a57-b0b8-2b29bb57ade1-2019-08-18T160312.829Z", "sop": "SOP6"}]}, "ensembl": {"gene": "ENSG00000083093", "protein": ["ENSP00000261584", "ENSP00000454703", "ENSP00000459237", "ENSP00000459882", "ENSP00000460666", "ENSP00000513284", "ENSP00000513285", "ENSP00000513286", "ENSP00000513287", "ENSP00000513288", "ENSP00000513289", "ENSP00000519074", "ENSP00000519075", "ENSP00000519076"], "transcript": ["ENST00000261584", "ENST00000561514", "ENST00000565038", "ENST00000566069", "ENST00000568219", "ENST00000697374", "ENST00000697375", "ENST00000697376", "ENST00000697377", "ENST00000697378", "ENST00000697379", "ENST00000697380", "ENST00000697381", "ENST00000697382", "ENST00000697383", "ENST00000697384", "ENST00000713772", "ENST00000713773", "ENST00000713774"], "translation": [{"protein": "ENSP00000459237", "rna": "ENST00000566069"}, {"protein": "ENSP00000459882", "rna": "ENST00000565038"}, {"protein": "ENSP00000261584", "rna": "ENST00000261584"}, {"protein": "ENSP00000519074", "rna": "ENST00000713772"}, {"protein": "ENSP00000454703", "rna": "ENST00000568219"}, {"protein": "ENSP00000519075", "rna": "ENST00000713773"}, {"protein": "ENSP00000513284", "rna": "ENST00000697374"}, {"protein": "ENSP00000519076", "rna": "ENST00000713774"}, {"protein": "ENSP00000513285", "rna": "ENST00000697376"}, {"protein": "ENSP00000513286", "rna": "ENST00000697377"}, {"protein": "ENSP00000460666", "rna": "ENST00000561514"}, {"protein": "ENSP00000513287", "rna": "ENST00000697379"}, {"protein": "ENSP00000513288", "rna": "ENST00000697382"}, {"protein": "ENSP00000513289", "rna": "ENST00000697383"}], "type_of_gene": "protein_coding"}, "entrezgene": "79728", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 29.3433687236, "exp_mis": 326.054383616, "exp_syn": 143.117938936, "lof_z": 1.70859139271492, "mis_z": -1.596697827275, "mu_lof": 2.15394009315e-06, "mu_mis": 2.8577654312e-05, "mu_syn": 1.22941250861e-05, "n_lof": 20.0, "n_mis": 385.0, "n_syn": 150.0, "p_li": 1.32628496864351e-10, "p_null": 0.229148631075892, "p_rec": 0.770851368791479, "syn_z": -0.356634568144707}, "bp": 3561, "cds_end": 23652478, "cds_start": 23614779, "n_exons": 13, "nonpsych": {"exp_lof": 26.2995318445, "exp_mis": 294.851641032, "exp_syn": 129.276504917, "lof_z": 2.16390606226146, "mis_z": -1.29680562755091, "mu_lof": 2.15394009315e-06, "mu_mis": 2.8577654312e-05, "mu_syn": 1.22941250861e-05, "n_lof": 15.0, "n_mis": 339.0, "n_syn": 137.0, "p_li": 2.32939341964646e-07, "p_null": 0.0315192884302344, "p_rec": 0.968480478630424, "syn_z": -0.427678944196284}, "nontcga": {"exp_lof": 26.9706499891, "exp_mis": 299.944804445, "exp_syn": 131.64326731, "lof_z": 2.08385685172761, "mis_z": -1.52621977642991, "mu_lof": 2.15394009315e-06, "mu_mis": 2.8577654312e-05, "mu_syn": 1.22941250861e-05, "n_lof": 16.0, "n_mis": 353.0, "n_syn": 139.0, "p_li": 5.16674380785053e-08, "p_null": 0.0439559841464461, "p_rec": 0.956043964186116, "syn_z": -0.40598124122736}, "transcript": "ENST00000261584.4"}, "exons": [{"cdsend": 23641157, "cdsstart": 23603458, "chr": "16", "position": [[23603164, 23603669], [23607863, 23608012], [23614003, 23614091], [23621361, 23621478], [23622968, 23623130], [23624008, 23624094], [23626235, 23626397], [23629203, 23629275], [23629639, 23630469], [23634861, 23636334], [23637849, 23637952], [23638069, 23638129], [23641109, 23641310]], "strand": -1, "transcript": "NM_024675", "txend": 23641310, "txstart": 23603164}], "exons_hg19": [{"cdsend": 23652478, "cdsstart": 23614779, "chr": "16", "position": [[23614485, 23614990], [23619184, 23619333], [23625324, 23625412], [23632682, 23632799], [23634289, 23634451], [23635329, 23635415], [23637556, 23637718], [23640524, 23640596], [23640960, 23641790], [23646182, 23647655], [23649170, 23649273], [23649390, 23649450], [23652430, 23652631]], "strand": -1, "transcript": "NM_024675", "txend": 23652631, "txstart": 23614485}], "generif": [{"pubmed": 16793542, "text": "FLJ21816 has been identified as a major binding protein of the breast cancer susceptibility protein BRCA2 and named \"PALB2\"."}, {"pubmed": 16793542, "text": "PALB2 colocalizes with BRCA2 in nuclear foci, promotes its localization and stability in key nuclear structures (e.g., chromatin and nuclear matrix), and enables its recombinational repair and checkpoint functions"}, {"pubmed": 17200668, "text": "The results show that PALB2 is a breast cancer susceptibility gene and further demonstrate the close relationship of the Fanconi anemia-DNA repair pathway and breast cancer predisposition."}, {"pubmed": 17200671, "text": "We identified pathogenic mutations in PALB2 (also known as FANCN) in seven families affected with Fanconi anemia and cancer in early childhood, demonstrating that biallelic PALB2 mutations cause a new subtype of Fanconi anemia, FA-N."}, {"pubmed": 17200672, "text": "we show that a defect in the BRCA2-interacting protein PALB2 is associated with Fanconi anemia in an individual with a new subtype."}, {"pubmed": 17287723, "text": "results indicate that PALB2 is a breast cancer susceptibility gene that, in a suitably mutant form, may also contribute to familial prostate cancer development"}, {"pubmed": 17420451, "text": "Some PALB2 mutations are associated with a substantially increased risk for breast cancer."}, {"pubmed": 18053174, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18053174, "text": "PALB2 can be added to the list of breast cancer susceptibility genes for which founder mutations have been identified in the French-Canadian population."}, {"pubmed": 18281473, "text": "Quantitative real-time reverse transcription-PCR showed PALB2 expression to be reduced 28-fold in primary breast tumor with PALB2 promoter hypermethylation compared with matched normal breast tissue RNA."}, {"pubmed": 18288683, "text": "Deleterious PALB2 mutations are unlikely to play a significant role in hereditary prostate cancer."}, {"pubmed": 18302019, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 18302019, "text": "We report the first example of LOH occurring in a PALB2-associated tumor. PALB2 loss of function might also conform to the inactivation model of a classic tumor-suppressor gene"}, {"pubmed": 18446436, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18446436, "text": "PALB2 germline mutations may have a role in early onset breast cancer in BRCA1/BRCA2 negative Chinese women"}, {"pubmed": 18501021, "text": "No large genomic rearrangements were identified in PALB2 in Finnish breast and/or ovarian cancer families"}, {"pubmed": 18557994, "text": "analysis of how the breast cancer genes ATM, BRIP1, PALB2 and CHEK2 affect risk for women with strong family histories [review]"}, {"pubmed": 18628482, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18628482, "text": "may be appropriate to offer PALB2 c.1592delT mutation testing to Finnish women with breast cancer"}, {"pubmed": 18637200, "text": "PALB2 appears not to be a significant factor in high-risk breast cancer families in Iceland and the 1592delT mutation is not seen to be associated with breast cancer in Iceland."}, {"pubmed": 18794107, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18794107, "text": "Our data suggest that the variants of PALB2 confer low-penetrance breast cancer susceptibility in a Chinese population."}, {"pubmed": 19011769, "text": "no defect in FANCD2 ubiquitination, BRCA2 and FANCJ expression; absence of FANCN protein in three cell lines: HT, Sudhl4 and JEKO-1."}, {"pubmed": 19264984, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19264984, "text": "a germline, truncating mutation in PALB2 that appeared responsible for the patient's predisposition to pancreatic cancer was identified; analysis of 96 patients with familial pancreatic cancer revealed 3 protein-truncating mutations in the PALB2 gene"}, {"pubmed": 19268590, "text": "BRCA1 is an upstream regulator of BRCA2 in the DNA-damage response, and PALB2 is the linker between BRCA1 and BRCA2 in breast and ovarian cancer."}, {"pubmed": 19308021, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19328558, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19333784, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19333784, "text": "deleterious mutations in PALB2 account for approximately 2% (1/48) of South African early-onset breast cancer"}, {"pubmed": 19369211, "text": "impaired homologous recombination repair is one of the fundamental causes for genomic instability and tumorigenesis observed in patients carrying BRCA1, BRCA2, or PALB2 mutations"}, {"pubmed": 19383810, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19383810, "text": "PALB2 1592delT is associated with an aggressive breast tumor phenotype."}, {"pubmed": 19423707, "text": "both PALB2 chromatin association and its oligomerization serve to secure the BRCA2 x RAD51 repair machinery at the sites of DNA damage"}, {"pubmed": 19504183, "text": "Our results suggest that large genomic deletions in BRIP1/FANCJ, PALB2/FANCN, and FANCD2 do not contribute significantly to the familial breast cancer risk in the Dutch population"}, {"pubmed": 19536649, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19553677, "text": "MRG15 is a novel PALB2-interacting factor involved in homologous recombination"}, {"pubmed": 19584259, "text": "Show here that PALB2 physically and functionally connects BRCA1 and BRCA2 into a DNA damage response network that also includes the RAD51 recombinase."}, {"pubmed": 19609323, "text": "structure explains the effects of both cancer-associated truncating mutants in PALB2 and missense mutations in the amino-terminal region of BRCA2."}, {"pubmed": 19690177, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19714462, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19748364, "text": "Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication."}, {"pubmed": 19763819, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19763819, "text": "We found no evidence to suggest that PALB2 mutation is an important breast cancer predisposition gene in an Irish breast cancer cohort"}, {"pubmed": 19763884, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19863560, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19863560, "text": "a predisposing mutation in PALB2,is present in approximately 6% of French-Canadian women with early-onset breast cancer"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19921424, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19921424, "text": "our findings further verified that some common PALB2 polymorphisms may contribute to the etiology of breast cancer in Chinese women"}, {"pubmed": 20003494, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20003494, "text": "Though any of the detected PALB2 variants do not associate to prostate cancer in population level in Finland it cannot be ruled out that some of these variants contribute to cancer susceptibility at individual level."}, {"pubmed": 20091115, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20091115, "text": "Our study provides no evidence that germline PALB2 mutations are associated with increased risk of male breast cancer"}, {"pubmed": 20122277, "text": "A novel germline PALB2 deletion is asociated with breast and ovarian cancer patients."}, {"pubmed": 20180015, "text": "Known variants of PALB2 in BRCA1/2 negative Italian male breast cancer patients did not play a major role in susceptibility. A new variant I1180T occurs in the WD40-4 conserved domain that regulates PALB2 interaction with BRCA2 and may be deleterious."}, {"pubmed": 20180015, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20213081, "text": "No 1592delT or 229delT mutations were found in any of the study cohort. These mutations are absent or rare in Korean patients who are negative for BRCA1 and BRCA2 mutations."}, {"pubmed": 20213081, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20412113, "text": "PALB2 mutations might contribute to hereditary pancreatic cancer in a small subset of Europeans with an additional occurrence of breast cancer."}, {"pubmed": 20582465, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20582465, "text": "germline mutations of PALB2 do not significantly contribute to cancer risk in non-BRCA1/2 cancer families with at least one patient with ovarian cancer, male breast cancer, and/or pancreatic cancer."}, {"pubmed": 20589654, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20722467, "text": "CHEK2, STK11, and PALB2 mutations or large genomic rearrangements of either STK11 or PALB2 are rare, and do not contribute to a substantial fraction of breast cancer susceptibility in high-risk French Canadian breast cancer families."}, {"pubmed": 20722467, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20852946, "text": "Mutations in PALB2 is associated with breast cancer."}, {"pubmed": 20871615, "text": "PALB2 binds DNA, especially D-loop structures, & interacts with the RAD51 recombinase to stimulate strand invasion. It can function synergistically with a BRCA2 chimera (termed piccolo, or piBRCA2) to further promote strand invasion."}, {"pubmed": 20871616, "text": "PALB2 binds DNA and physically interacts with RAD51 to enhance RAD51's ability to form the D loop. Although PALB2 alone stimulates D-loop formation, it has a cooperative effect with RAD51AP1, an enhancer of RAD51."}, {"pubmed": 20872766, "text": "findings support PALB2 and BRCA2 as risk genes specifically for bipolar disorder, and suggest that altered DNA repair related to neurogenesis may be involved in BD pathophysiology"}, {"pubmed": 20927582, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20927582, "text": "males who develop breast cancer may have mutations in BRCA2, and possibly in PALB2"}, {"pubmed": 21113654, "text": "Germline mutations in PALB2 are not associated with African-American breast cancer."}, {"pubmed": 21153565, "text": "deleterious PALB2 mutations are unlikely to play a significant role in familial melanoma."}, {"pubmed": 21165770, "text": "PALB2 germline mutations account for a small, but not negligible, proportion of bilateral breast carcinomas in German and Russian populations"}, {"pubmed": 21182766, "text": "the PALB2 c.3113G > A mutation appears to be associated with substantial risks of breast cancer that are of clinical relevance"}, {"pubmed": 21184274, "text": "PALB2 mutations are not preferentially associated with breast cancer families with cases of pancreatic cancer"}, {"pubmed": 21285249, "text": "Data indicate that PALB2 heterozygotes were 4-fold more likely to have a male relative with breast cancer, 6-fold more likely to have a relative with pancreatic cancer and 1.3-fold more likely to have a relative with ovarian cancer."}, {"pubmed": 21356067, "text": "The PALB2 gene was screened for mutations in well-characterized, Finnish, high-risk hereditary breast and/or ovarian cancer individuals."}, {"pubmed": 21365267, "text": "PALB2 mutations occur with a prevalence of 2.1% in a population of BRCA1/2-negative breast cancer patients specifically selected for a personal and/or family history of pancreatic cancer."}, {"pubmed": 21409391, "text": "PALB2 mutations are present in a small but substantial proportion of inherited breast cancer cases, and indicates that RAD51C at a population level does not account for a substantial number of familial breast cancer cases"}, {"pubmed": 21415078, "text": "Mutations within the PALB2 gene are rare events that do not account for a substantial proportion of cancer susceptibility in breast-pancreas cancer families."}, {"pubmed": 21614589, "text": "Germline PALB2 mutations are not associated with melanoma-prone families with CDKN2A mutations and pancreatic cancer"}, {"pubmed": 21618343, "text": "these observations indicate a low prevalence of deleterious PALB2 mutations and a specific mutation profile within the German population."}, {"pubmed": 21637299, "text": "BRCA2 and PALB2 are main regulators of G2 checkpoint maintenance following DNA-damage."}, {"pubmed": 21932393, "text": "PALB2 mutations were present in both familial and nonfamilial breast cancers among African Americans. Rare PALB2 mutations accounted for a small but substantial proportion of patients with breast cancer."}, {"pubmed": 21989927, "text": "Gene deletions in the PALB2 gene is not associated with pancreatic cancer."}, {"pubmed": 22052327, "text": "Our study does not support an enrichment of PALB2 germline mutations in the subset of breast cancer families with male breast cancer cases."}, {"pubmed": 22193777, "text": "These results suggest that PALB2 chromatin association via ChAM facilitates PALB2 function in the cellular resistance to DNA damage."}, {"pubmed": 22194698, "text": "BRCA2 fusion peptide deleted for the DNA binding domain and active in homologous recombination is completely dependent on interaction with the PALB2 tumor suppressor for activity"}, {"pubmed": 22241545, "text": "rare PALB2 missense mutations strongly influence breast cancer risk"}, {"pubmed": 22310028, "text": "PALB2 mutations in ovarian cancer patients from the Volga-Ural region of Russia"}, {"pubmed": 22331464, "text": "PALB2 promotes NRF2 accumulation and function in the nucleus and lowers the cellular reactive oxygen species (ROS) level. In addition, PALB2 also regulates the rate of NRF2 export from the nucleus following induction"}, {"pubmed": 22505525, "text": "PALB2 emerges as the third breast cancer susceptibility gene"}, {"pubmed": 22692731, "text": "germline mutations in BRIP1 and PALB2 contribute marginally to breast cancer susceptibility in ethnically diverse, Jewish high risk families"}, {"pubmed": 23038782, "text": "PALB2 localization depends on the presence of MDC1, RNF8, RAP80 and Abraxas upstream of BRCA1."}, {"pubmed": 23110154, "text": "Data show a substantial proportion of germ-line mutations in triple-negative breast cancer (TNBC), with a preponderance of BRCA1 mutations over mutations in BRCA2 or PALB2, but no evidence to implicate BRD7 mutations in the etiology of TNBC."}, {"pubmed": 23302520, "text": "Our findings, taken together with previous reports, support adding PALB2 c.2323C>T p.Q775X to the list of cancer susceptibility genes for which founder mutations have been identified in the French Canadian population."}, {"pubmed": 23341105, "text": "Critical nuclear organization defects are associated with the predisposition to transformation and early stage development of PALB2-related breast cancers."}, {"pubmed": 23448497, "text": "About 1.5% (95% CI 0.6to 2.4) of Australasian multiple-case breast cancer families attending clinics are segregating protein-truncating mutations in PALB2, most being PALB2 c.3113G>A, p.Trp1038*."}, {"pubmed": 23471749, "text": "PALB2 c.3113G>A mutation is associated with contra-lateral breast cancers."}, {"pubmed": 23561644, "text": "These findings question the causal mechanisms of ATM and PALB2 in families with pancreatic cancer."}, {"pubmed": 23657012, "text": "Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer."}, {"pubmed": 23758548, "text": "A new somatic frameshift mutation of a tumor suppressor gene PALB2 has been identified in patients with gastric and colorectal cancers with microsatellite instability."}, {"pubmed": 23787919, "text": "breast tumours arising in PALB2 mutation carriers were associated with minimal sclerosis; minimal sclerosis was also a feature that distinguished PALB2 mutation carriers from BRCA1 and BRCA2 mutation carriers"}, {"pubmed": 23824750, "text": "Germline PALB2 mutations are of low prevalence in Australian triple-negative breast cancer"}, {"pubmed": 23846919, "text": "Studies indicate that germline mutations in BRCA1/2 and related genes, such as PALB2, are associated with pancreatic cancer."}, {"pubmed": 23935836, "text": "The goal of this study was to determine the prevalence of PALB2 mutations in a population of BRCA1/BRCA2 negative breast cancer patients selected from either a personal or family history of pancreatic cancer."}, {"pubmed": 23977390, "text": "These results indicate a low prevalence of deleterious PALB2 mutations and a specific mutation profile within the Malaysian and Singaporean populations."}, {"pubmed": 24061862, "text": "These data indicate that the PALB2*c.509_510delGA mutation is prevalent in about 1 in 400 breast cancer patients from Central and Eastern Europe, and the low occurrence of familial clustering is consistent with a moderate penetrance of this mutation."}, {"pubmed": 24136930, "text": "The highest frequency of PALB2 mutations (comparable with that previously reported for BRCA2) was found in a subgroup of patients with hereditary breast cancer."}, {"pubmed": 24141787, "text": "three different cancer susceptibility and Fanconi anemia proteins function in a DNA repair pathway based upon the PALB2 WD40 domain binding to RAD51C and BRCA2."}, {"pubmed": 24153426, "text": "Heterozygous mutations in PALB2 cause DNA replication and DNA damage response defects."}, {"pubmed": 24285729, "text": "both BRCA1 and PALB2 are required for BRCA2-focus formation when the DBD is absent."}, {"pubmed": 24415441, "text": "Results suggest that PALB2 mutations occur at a frequency of ~1% in patients with hereditary breast cancer."}, {"pubmed": 24460267, "text": "PALB2 genetic variants confer susceptibility to breast cancer."}, {"pubmed": 24485656, "text": "PALB2 and BRCA2, in addition to their functions in D loop formation, play crucial roles in the initiation of recombination-associated DNA synthesis by Poleta-mediated DNA repair."}, {"pubmed": 24556926, "text": "in the Italian population also, deleterious mutations of PALB2 are relatively frequent predisposing factors for breast cancer and may be associated with high risk of the disease."}, {"pubmed": 24591564, "text": "Taken together, these results highlight an important role for breast cancer proteins BRCA1 and PALB2 in the regulation of diverse growth regulatory pathways."}, {"pubmed": 24870022, "text": "overview of the molecular mechanisms that underlie the tumour suppressor function of PALB2; also provide a molecular description of Fanconi's anaemia- or cancer-associated PALB2 mutations [review]"}, {"pubmed": 24949998, "text": "Overall our data do not support a case for PALB2 being associated with melanoma predisposition."}, {"pubmed": 24998779, "text": "The PALB2 network appears to mediate the maintenance of genome stability, may explain the association of many of the corresponding genes with similar spectra of tumors, and could present novel therapeutic opportunities. [review]"}, {"pubmed": 25099575, "text": "Loss-of-function mutations in PALB2 are an important cause of hereditary breast cancer. Our data suggest the breast-cancer risk for PALB2 mutation carriers may overlap with that for BRCA2 mutation carriers."}, {"pubmed": 25113031, "text": "Expression of mutant RPA2 or loss of PALB2 expression led to significant DNA damage after replication stress, a defect accentuated by poly-ADP (adenosine diphosphate) ribose polymerase inhibitors."}, {"pubmed": 25263539, "text": "PALB2 mutation is associated with response to therapy in neoplasms."}, {"pubmed": 25328949, "text": "Women who carry a mutated version of PULB2 gene have an increased risk of developing breast cancer."}, {"pubmed": 25356972, "text": "Germ-line DNA samples from 727 unrelated probands with positive family history (521 met criteria for familial pancreatic cancer) were tested for mutations in BRCA1 and BRCA2, PALB2, and CDKN2A."}, {"pubmed": 25529982, "text": "This study showed the presence of a PALB2 truncating mutation in a case of male breast cancer."}, {"pubmed": 25542327, "text": "Mutations in the PALB2 gene are responsible for a small but significant percentage of cancer risks in familial breast and pancreatic cancer families"}, {"pubmed": 25636233, "text": "Our results suggest that PALB2 c.1676A > G and c.2993C > T play roles in BC risk in women with a strong family history of BC."}, {"pubmed": 25666743, "text": "Novel PALB2 mutation was found in a cohort of Italian breast cancer patients."}, {"pubmed": 25794774, "text": "Truncating PALB2 mutations were detected in families with breast cancer negative for which a BRCA1 or BRCA2 mutation has not been found."}, {"pubmed": 25833210, "text": "Two novel heterozygous mutations predicted to alter the function of PALB2 were identified (c.2014G>C, p.E672Q and c.2993G>A, p.G998E). Notably, both of these mutations co-existed in BRCA1 and BRCA2 families"}, {"pubmed": 25959805, "text": "Women with a PALB2 mutation face an increased risk of breast cancer and might be at a higher risk of death from breast cancer compared with non-carriers."}, {"pubmed": 26219241, "text": "PALB2 Mutation is associated with Breast Cancer."}, {"pubmed": 26283626, "text": "The truncating variants in PALB2 as high-penetrance breast cancer susceptibility alleles."}, {"pubmed": 26411315, "text": "PALB2 germline mutations are associated with breast and/or ovarian cancer."}, {"pubmed": 26489409, "text": "PALB2 mutations account for a small, but not negligible, proportion of patients with hereditary predisposition to breast cancer in the Xinjing region of China."}, {"pubmed": 26526077, "text": "87 out of 91 (95.6%) primary tumors were positive for PALB2 expression, as checked at the mRNA level."}, {"pubmed": 26564480, "text": "PALB2 mutations make a small contribution to the heritable breast cancer susceptibility in French population."}, {"pubmed": 26577449, "text": "The aim of this study was to determine the frequency and spectrum of germline mutations in BRCA1, BRCA2 and PALB2 and to evaluate the presence of the CHEK2 c.1100delC allele in these patients."}, {"pubmed": 26640152, "text": "Data show an increase of error-prone single-strand annealing (SSA) and microhomology-mediated end-joining (MMEJ) in the PALB2 (partner and localizer of BRCA2) c.1592delT mutation carriers."}, {"pubmed": 26645143, "text": "a foundation for the formation and bioactivity of the G-quadruplex in the promoter region of PALB2 gene"}, {"pubmed": 26981788, "text": "rs120963 and rs249954 of the PALB2 gene are associated with increased breast cancer risk, and the association of rs249935 with breast cancer risk may be modified by the tumor pathological characteristics."}, {"pubmed": 26990772, "text": "Although patient cells were unable to form Rad51 foci following exposure to either DNA damaging agent, U2OS cells, in which the mutant PALB2 with in frame skip of exon 6 was induced, did show recruitment of Rad51 to foci following damage."}, {"pubmed": 27106063, "text": "PALB2 mutations are associated with susceptibility to Pancreatic ductal adenocarcinoma in the Czech Republic."}, {"pubmed": 27113759, "text": "our findings highlight a critical importance of PALB2 phosphorylation as a novel regulatory step in genome maintenance after genotoxic stress."}, {"pubmed": 27277787, "text": "FANCD2 and PALB2, as indicators of the upstream and downstream arms, respectively, colocalize independently of each other in response to DNA damage."}, {"pubmed": 27328445, "text": "Germline mutation in PALB2 gene is associated with neoadjuvant therapy response in triple negative breast patients."}, {"pubmed": 27464310, "text": "In this paper, we describe an extension to the BOADICEA model to incorporate the effects of intermediate risk variants for breast cancer, specifically loss of function mutations in the three genes for which the evidence for association is clearest and the risk estimates most precise: PALB2, CHEK2 and ATM"}, {"pubmed": 27469594, "text": "Study have shown that mutations in BRCA1, BRCA2, and PALB2 account for more than 10 % of breast cancer in Trinidad and Tobago. 25 different mutations identified; of these, four mutations were seen in two patients each."}, {"pubmed": 27490902, "text": "we describe a genetic approach to examine the functional significance of the interaction between BRCA2 and PALB2 by generating a knock-in mouse model of Brca2 carrying a single amino acid change (Gly25Arg, Brca2G25R) that disrupts this interaction. In addition, we have combined Brca2G25R homozygosity as well as hemizygosity with Palb2 and Trp53 heterozygosity ."}, {"pubmed": 27573125, "text": "Results identified novel intronic mutations in PALB2 gene associated with early-onset breast cancer patients from Turkey. PABL2 mutations accounted for 4.03 % in BRCA1/2-negative Turkish patients."}, {"pubmed": 27595995, "text": "PALB2 rare variants were associated with an increased risk of breast cancer."}, {"pubmed": 27624329, "text": "We identified two PALB2 mutations that are founder alleles in Italian families, one of which is, independently, also a founder mutation in American-Hispanic breast cancers."}, {"pubmed": 27631815, "text": "Prevalence of germline PALB2 mutations among women with epithelial ovarian cancer in Ontario"}, {"pubmed": 27648926, "text": "PALB2 is involved in BC risk."}, {"pubmed": 27757719, "text": "Our results indicate that the PALB2 exon 13 duplication is a pathogenic variant. The presence of the PALB2 duplication in the proband affected with high-grade serous ovarian cancer suggests that PALB2 might be associated with a predisposition to ovarian cancer."}, {"pubmed": 28024868, "text": "Germline PALB2 mutation was found in patients with hereditary and sporadic gastric cancer."}, {"pubmed": 28124401, "text": "PALB2 mutation along with BRCA1 mutation confers chemoresistance in breast cancer."}, {"pubmed": 28158555, "text": "identification of a hidden nuclear export signal (NES) within the WD40 domain of PALB2 and found that the W1038X truncation leads to the exposure of this NES to CRM1, an export protein"}, {"pubmed": 28194609, "text": "The results of the present study suggest that mutations in the PALB2 gene may be particularly relevant to breast cancer susceptibility in the Jamaican population."}, {"pubmed": 28240985, "text": "The findings demonstrate that RNF168 couples PALB2-dependent homologous recombination to H2A ubiquitylation to promote DNA repair and preserve genome integrity."}, {"pubmed": 28279176, "text": "Germline mutations in the PALB2 gene were observed at a frequency of approximately 1.5% in Polish breast and/or ovarian cancer patients"}, {"pubmed": 28319063, "text": "Findings establish L35P as the first pathogenic missense mutation in PALB2 and directly demonstrate the requirement of the PALB2-BRCA1 interaction for breast cancer suppression."}, {"pubmed": 28418444, "text": "inherited pathogenic variants in PALB2 were associated with high risks of breast cancer"}, {"pubmed": 28673974, "text": "PALB2 associates with active genes through its major binding partner, MRG15, which recognizes histone H3 trimethylated at lysine 36 (H3K36me3) by the SETD2 methyltransferase"}, {"pubmed": 28779002, "text": "Truncating variants in PALB2, ATM and CHEK2 , but not XRCC2 were associated with increased breast cancer risk."}, {"pubmed": 28791855, "text": "Studies suggest that people with high risk of breast cancer and negative BRCA1/BRCA2 should be tested for PALB2 mutations."}, {"pubmed": 28796317, "text": "We showed that the mutation frequency of RAD51C in Japanese familial breast cancer cases was similar to that in Western countries and that the prevalence of deleterious mutation of PALB2 was possibly lower. Furthermore, our results suggested that BRIP1 mutation frequency in Japan might differ from that in Western countries"}, {"pubmed": 28825143, "text": "Our data presented the germline mutation status of PALB2 in Chinese breast cancer patients, suggesting that loss-of-function germline mutations of PALB2 are important in both familial and sporadic breast cancer. Clinically, these data may be helpful in genetic counseling of breast cancer patients with PALB2 germline mutation."}, {"pubmed": 28858227, "text": "the involvement of PALB2 mutations in the predisposition to cancer and the role of PALB2 in stimulating error-free DNA repair through the FA/HR pathway."}, {"pubmed": 29431189, "text": "that PALB2 does undergo bi-allelic inactivation in the majority of breast cancers from PALB2 germline mutation carriers"}, {"pubmed": 29470806, "text": "Our findings indicate that in the Indian population, there is a high prevalence of mutations in the high-risk breast cancer genes: BRCA1, BRCA2, TP53, and PALB2."}, {"pubmed": 29706558, "text": "We identified a cluster of interacting genes involved in DNA repair that could be associated with predisposition to hereditary diffuse gastric cancer, in particular, PALB2."}, {"pubmed": 29802286, "text": "Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma"}, {"pubmed": 29988077, "text": "Our results validate the integration of PALB2, RAD51C, and RAD51D in the diagnosis of hereditary breast and ovarian cancer and suggest that the other genes are involved in an oligogenic determinism."}, {"pubmed": 30255452, "text": "PALB2 c.18G>T (p.Gly6=) variant disrupts normal splicing and leads to several abnormal transcripts, which presumably leads to premature protein truncation and this variant likely contributes to cancer predisposition through disruption of normal splicing."}, {"pubmed": 30309218, "text": "Study have identified one novel pathogenic and four potentially pathogenic PALB2 mutations, three being novel in 370 Pakistani early-onset and familial breast/ovarian cancer patients. The frequency of PALB2 mutations in patients with familial breast cancer was 0.8%. These findings show that PALB2 mutations account for a small proportion of early-onset and hereditary breast/ovarian cancer cases in Pakistan."}, {"pubmed": 30337689, "text": "Study shows that BRCA1, PALB2 and BRCA2 can all play a significant role in both checkpoint activation and checkpoint maintenance, depending on cell type and context, and that PALB2 links BRCA1 and BRCA2 in the checkpoint response. The BRCA1-PALB2 interaction can be important for checkpoint activation, whereas PALB2-BRCA2 complex appears to be more critical for checkpoint maintenance."}, {"pubmed": 30362319, "text": "The associations between five SNPs of PALB2 and breast cancer risk."}, {"pubmed": 30458447, "text": "Study suggests that single nucleotide polymorphisms in the PALB2 loci rs120963/rs249935/rs447529, but not in the other 3 loci (rs152451/rs8053188/rs16940342), may contribute to breast cancer susceptibility.[meta-analysis]"}, {"pubmed": 30521987, "text": "Study found a frameshift mutation which segregates in an early onset HBOC family; and four rare missense variants. None of the variants tested for a predicted splicing disruption showed an aberrant transcript pattern. Although PALB2 truncating mutations are rarely identified, segregation analysis and early onset cancer suggest a significant contribution to HBOC susceptibility in the Spanish population."}, {"pubmed": 30552643, "text": "Results support a pathogenic classification for PALB2 c.3201+5G>T, highlighting the impact of variants causing an imbalanced expression of natural RNA isoforms in breast cancer susceptibility."}, {"pubmed": 30613976, "text": "Results found that PALB2 was the most frequently altered gene (1.2%) and PALB2 pathogenic variants were significantly associated with high risk of breast cancer in men."}, {"pubmed": 30614742, "text": "PALB2 variant is associated with hematological malignancies."}, {"pubmed": 31017574, "text": "These data reveal a versatile DNA interaction property of PALB2 and demonstrate a critical role of PALB2 DNA binding for chromosome repair in cells."}, {"pubmed": 31089269, "text": "Genetic testing for PALB2, especially for the Greek founder c.2257C>T truncating variant, should be seriously considered in Greek breast cancer cases, since such findings could assist appropriate clinical management for the patients and their families."}, {"pubmed": 31206626, "text": "PALB2 pathogenic variants in the BRCA-negative Hispanic women with breast cancer."}, {"pubmed": 31586400, "text": "the effects of 44 PALB2 variants of uncertain significance found in breast cancer patients were examined."}, {"pubmed": 31619740, "text": "A systematic review of predicted pathogenic PALB2 variants: an analysis of mutational overlap between epithelial cancers."}, {"pubmed": 31636395, "text": "Functional characterization of 84 PALB2 variants of uncertain significance."}, {"pubmed": 31685642, "text": "USP22 Interacts with PALB2 and Promotes Chemotherapy Resistance via Homologous Recombination of DNA Double-Strand Breaks."}, {"pubmed": 31841383, "text": "Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families."}, {"pubmed": 32029870, "text": "Germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors."}, {"pubmed": 32041954, "text": "Depleting p53-binding protein 1 (53BP1) in BRCA1-null cells restores partner and localizer of BRCA2 (PALB2) accrual at resected DNA double-strand breaks (DSBs). PALB2 DSB recruitment in BRCA1/53BP1-deficient cells is mediated by an interaction between PALB2's chromatin associated motif (ChAM) and the nucleosome acidic patch region."}, {"pubmed": 32048105, "text": "Missense PALB2 germline variant disrupts nuclear localization of PALB2 in a patient with breast cancer."}, {"pubmed": 32058061, "text": "BRCA and PALB2 mutations in a cohort of male breast cancer with one bilateral case."}, {"pubmed": 32300229, "text": "Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls."}, {"pubmed": 32339256, "text": "Spectrum of PALB2 germline mutations and characteristics of PALB2-related breast cancer: Screening of 16,501 unselected patients with breast cancer and 5890 controls by next-generation sequencing."}, {"pubmed": 32531196, "text": "Validation of a next generation sequencing assay for BRCA1, BRCA2, CHEK2 and PALB2 genetic testing."}, {"pubmed": 32546565, "text": "Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer."}, {"pubmed": 32669374, "text": "A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer."}, {"pubmed": 32996020, "text": "Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations."}, {"pubmed": 32997802, "text": "Frequency and molecular characteristics of PALB2-associated cancers in Russian patients."}, {"pubmed": 33139182, "text": "PALB2 Variants: Protein Domains and Cancer Susceptibility."}, {"pubmed": 33169439, "text": "The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise the DNA damage response."}, {"pubmed": 33186520, "text": "Elevated CXorf67 Expression in PFA Ependymomas Suppresses DNA Repair and Sensitizes to PARP Inhibitors."}, {"pubmed": 33414401, "text": "Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway."}, {"pubmed": 33512806, "text": "Investigation on the Role of PALB2 Gene in CDH1-Negative Patients With Hereditary Diffuse Gastric Cancer."}, {"pubmed": 33536619, "text": "BRCA1 and RNAi factors promote repair mediated by small RNAs and PALB2-RAD52."}, {"pubmed": 33811135, "text": "Characterisation of protein-truncating and missense variants in PALB2 in 15 768 women from Malaysia and Singapore."}, {"pubmed": 33854214, "text": "Familial wild-type gastrointestinal stromal tumour in association with germline truncating variants in both SDHA and PALB2."}, {"pubmed": 33964450, "text": "A Validated Functional Analysis of Partner and Localizer of BRCA2 Missense Variants for Use in Clinical Variant Interpretation."}, {"pubmed": 34006922, "text": "PALB2 mutations and prostate cancer risk and survival."}, {"pubmed": 34036661, "text": "Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population."}, {"pubmed": 34113003, "text": "Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer."}, {"pubmed": 34245638, "text": "Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and PALB2 in endometrial cancer."}, {"pubmed": 34408138, "text": "RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage."}, {"pubmed": 34687993, "text": "Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2)."}, {"pubmed": 34846068, "text": "Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants."}, {"pubmed": 34946951, "text": "Structural Insight into the Mechanism of PALB2 Interaction with MRG15."}, {"pubmed": 35277653, "text": "Detection of a pathogenic Alu element insertion in PALB2 gene from targeted NGS diagnostic data."}, {"pubmed": 35363308, "text": "Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program."}, {"pubmed": 35396271, "text": "Contribution of large genomic rearrangements in PALB2 to familial breast cancer: implications for genetic testing."}, {"pubmed": 35608067, "text": "Germline mutations in Chinese ovarian cancer with or without breast cancer."}, {"pubmed": 35610400, "text": "PALB2 germline mutations in a multi-gene panel testing cohort of 1905 breast-ovarian cancer patients in Argentina."}, {"pubmed": 35762214, "text": "Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma."}, {"pubmed": 36175305, "text": "Contribution of germline PALB2 variants to an unselected and prospectively registered pancreatic cancer patient cohort in Pakistan."}, {"pubmed": 36411032, "text": "UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2."}, {"pubmed": 36623243, "text": "Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2."}, {"pubmed": 36758349, "text": "Study on TFF1 and PALB2 gene variants associated with gastric carcinoma risk in the Chinese Han population."}, {"pubmed": 36997402, "text": "Low Expression of PALB2 is Associated With Poor Survival in Chinese Women With Primary Breast Cancer."}, {"pubmed": 37169825, "text": "PALB2 germline mutations in a large cohort of Middle Eastern breast-ovarian cancer patients."}, {"pubmed": 37515473, "text": "Factors that differentiate cancer risk management decisions among females with pathogenic/likely pathogenic variants in PALB2, CHEK2, and ATM."}, {"pubmed": 37592023, "text": "Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk."}, {"pubmed": 38061684, "text": "Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations."}, {"pubmed": 38597967, "text": "PALB2-mutated human mammary cells display a broad spectrum of morphological and functional abnormalities induced by increased TGFbeta signaling."}, {"pubmed": 38914840, "text": "Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in China."}], "genomic_pos": {"chr": "16", "end": 23641321, "ensemblgene": "ENSG00000083093", "start": 23603160, "strand": -1}, "genomic_pos_hg19": {"chr": "16", "end": 23652631, "start": 23614488, "strand": -1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0000724", "qualifier": "involved_in", "term": "double-strand break repair via homologous recombination"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0000724", "pubmed": [19369211, 19423707, 28398198], "qualifier": "involved_in", "term": "double-strand break repair via homologous recombination"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0000724", "pubmed": 26323318, "qualifier": "involved_in", "term": "double-strand break repair via homologous recombination"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001756", "qualifier": "involved_in", "term": "somitogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001833", "qualifier": "involved_in", "term": "inner cell mass cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006915", "qualifier": "involved_in", "term": "apoptotic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007498", "qualifier": "involved_in", "term": "mesoderm development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009887", "qualifier": "involved_in", "term": "animal organ morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035264", "qualifier": "involved_in", "term": "multicellular organism growth"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0036342", "qualifier": "involved_in", "term": "post-anal tail morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043066", "qualifier": "involved_in", "term": "negative regulation of apoptotic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048568", "qualifier": "involved_in", "term": "embryonic organ development"}], "CC": [{"evidence": "NAS", "gocategory": "CC", "id": "GO:0005634", "pubmed": 19369211, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "is_active_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016607", "qualifier": "located_in", "term": "nuclear speck"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0032991", "pubmed": 26833090, "qualifier": "part_of", "term": "protein-containing complex"}, {"evidence": "IPI", "gocategory": "CC", "id": "GO:1990391", "pubmed": 19369211, "qualifier": "part_of", "term": "DNA repair complex"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0003677", "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003677", "pubmed": 20871616, "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [17420451, 19369211, 19423707, 19609323, 20332121, 20871616, 22193777, 22244764, 22293751, 24141787, 24485656, 25960410, 26649820, 26833090, 28319063, 28514442, 29656893, 30410870, 32296183, 34591612], "qualifier": "enables", "term": "protein binding"}]}, "homologene": {"genes": [[9031, 416572], [9544, 700843], [9598, 453988], [9606, 79728], [9615, 608527], [9913, 507620], [10090, 233826], [10116, 293452]], "id": 11652}, "interpro": [{"desc": "WD40/YVTN repeat-like-containing domain superfamily", "id": "IPR015943", "short_desc": "WD40/YVTN_repeat-like_dom_sf"}, {"desc": "Partner and localiser of BRCA2, WD40 domain", "id": "IPR031920", "short_desc": "PALB2_WD40"}, {"desc": "WD40-repeat-containing domain superfamily", "id": "IPR036322", "short_desc": "WD40_repeat_dom_sf"}, {"desc": "Partner and localizer of BRCA2", "id": "IPR042417", "short_desc": "PALB2"}], "ipi": "IPI00172559", "map_location": "16p12.2", "name": "partner and localizer of BRCA2", "other_names": ["mutant partner and localizer of BRCA2", "partner and localizer of BRCA2"], "pantherdb": {"HGNC": "26144", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "3040695", "ortholog_type": "LDO", "panther_family": "PTHR14662", "taxid": 10090, "uniprot_kb": "Q3U0P1"}, {"RGD": "1304759", "ortholog_type": "LDO", "panther_family": "PTHR14662", "taxid": 10116, "uniprot_kb": "D3ZM14"}, {"Ensembl": "ENSGALG00000006078", "ortholog_type": "LDO", "panther_family": "PTHR14662", "taxid": 9031, "uniprot_kb": "F1NAU2"}], "uniprot_kb": "Q86YC2"}, "pathway": {"kegg": [{"id": "hsa03440", "name": "Homologous recombination - Homo sapiens (human)"}, {"id": "hsa03460", "name": "Fanconi anemia pathway - Homo sapiens (human)"}], "pid": {"id": "fanconi_pathway", "name": "Fanconi anemia pathway"}, "reactome": [{"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-2262752", "name": "Cellular responses to stress"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-5685942", "name": "HDR through Homologous Recombination (HRR)"}, {"id": "R-HSA-5693532", "name": "DNA Double-Strand Break Repair"}, {"id": "R-HSA-5693537", "name": "Resolution of D-Loop Structures"}, {"id": "R-HSA-5693538", "name": "Homology Directed Repair"}, {"id": "R-HSA-5693554", "name": "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"}, {"id": "R-HSA-5693567", "name": "HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)"}, {"id": "R-HSA-5693568", "name": "Resolution of D-loop Structures through Holliday Junction Intermediates"}, {"id": "R-HSA-5693579", "name": "Homologous DNA Pairing and Strand Exchange"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-73894", "name": "DNA Repair"}, {"id": "R-HSA-8951664", "name": "Neddylation"}, {"id": "R-HSA-8953897", "name": "Cellular responses to stimuli"}, {"id": "R-HSA-9675135", "name": "Diseases of DNA repair"}, {"id": "R-HSA-9675136", "name": "Diseases of DNA Double-Strand Break Repair"}, {"id": "R-HSA-9701190", "name": "Defective homologous recombination repair (HRR) due to BRCA2 loss of function"}, {"id": "R-HSA-9701192", "name": "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"}, {"id": "R-HSA-9701193", "name": "Defective homologous recombination repair (HRR) due to PALB2 loss of function"}, {"id": "R-HSA-9704331", "name": "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"}, {"id": "R-HSA-9704646", "name": "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"}, {"id": "R-HSA-9709603", "name": "Impaired BRCA2 binding to PALB2"}, {"id": "R-HSA-9711123", "name": "Cellular response to chemical stress"}, {"id": "R-HSA-9755511", "name": "KEAP1-NFE2L2 pathway"}], "wikipathways": {"id": "WP4946", "name": "DNA Repair Pathways Full Network"}}, "pdb": ["2W18", "3EU7", "7S4A"], "pfam": "PF16756", "pharmgkb": "PA162398608", "pharos": {"target_id": 5478, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF172549", "relationship": "is"}, {"id": "GNF183455", "relationship": "is"}, {"id": "GNF194361", "relationship": "is"}, {"id": "GNF205267", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF033860", "relationship": "is"}, {"id": "GNF045587", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF005101", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF244745", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF102646", "relationship": "is"}, {"id": "GNF112481", "relationship": "is"}, {"id": "GNF152122", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000016.10", "NC_060940.1", "NG_007406.1"], "protein": ["NP_001394225.1", "NP_001394226.1", "NP_001394227.1", "NP_001394228.1", "NP_001394229.1", "NP_001394230.1", "NP_001394231.1", "NP_001394233.1", "NP_001394234.1", "NP_001394235.1", "NP_001394236.1", "NP_001394237.1", "NP_001394238.1", "NP_001394239.1", "NP_001394240.1", "NP_001394241.1", "NP_001394242.1", "NP_001394243.1", "NP_078951.2"], "rna": ["NM_001407296.1", "NM_001407297.1", "NM_001407298.1", "NM_001407299.1", "NM_001407300.1", "NM_001407301.1", "NM_001407302.1", "NM_001407304.1", "NM_001407305.1", "NM_001407306.1", "NM_001407307.1", "NM_001407308.1", "NM_001407309.1", "NM_001407310.1", "NM_001407311.1", "NM_001407312.1", "NM_001407313.1", "NM_001407314.1", "NM_024675.4"], "translation": [{"protein": "NP_001394235.1", "rna": "NM_001407306.1"}, {"protein": "NP_001394241.1", "rna": "NM_001407312.1"}, {"protein": "NP_001394226.1", "rna": "NM_001407297.1"}, {"protein": "NP_001394236.1", "rna": "NM_001407307.1"}, {"protein": "NP_001394238.1", "rna": "NM_001407309.1"}, {"protein": "NP_001394243.1", "rna": "NM_001407314.1"}, {"protein": "NP_001394227.1", "rna": "NM_001407298.1"}, {"protein": "NP_001394240.1", "rna": "NM_001407311.1"}, {"protein": "NP_001394234.1", "rna": "NM_001407305.1"}, {"protein": "NP_001394239.1", "rna": "NM_001407310.1"}, {"protein": "NP_001394228.1", "rna": "NM_001407299.1"}, {"protein": "NP_001394233.1", "rna": "NM_001407304.1"}, {"protein": "NP_001394242.1", "rna": "NM_001407313.1"}, {"protein": "NP_001394231.1", "rna": "NM_001407302.1"}, {"protein": "NP_001394230.1", "rna": "NM_001407301.1"}, {"protein": "NP_001394225.1", "rna": "NM_001407296.1"}, {"protein": "NP_001394237.1", "rna": "NM_001407308.1"}, {"protein": "NP_001394229.1", "rna": "NM_001407300.1"}, {"protein": "NP_078951.2", "rna": "NM_024675.4"}]}, "reporter": {"HG-U133_Plus_2": "219530_at", "HG-U95B": "47111_at", "HTA-2_0": "TC16000967.hg.1", "HuEx-1_0": "3685329", "HuGene-1_1": "8000329", "HuGene-2_1": "16825104"}, "retired": 146420, "summary": "This gene encodes a protein that may function in tumor suppression. This protein binds to and colocalizes with the breast cancer 2 early onset protein (BRCA2) in nuclear foci and likely permits the stable intranuclear localization and accumulation of BRCA2. [provided by RefSeq, Jul 2008].", "symbol": "PALB2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1835898"}, "unigene": "Hs.444664", "uniprot": {"Swiss-Prot": "Q86YC2", "TrEMBL": ["H3BN63", "A0AA52I2C1", "A0A8V8TKZ4", "A0A8V8TMC9", "A0A8V8TLC8", "I3L2S5", "A0A8V8TMK8", "I3L1Z5"]}, "wikipedia": {"url_stub": "PALB2"}}